NALM6/iRFP cells are derived from the human precursor B cell lymphoblast cell line NALM6 by stably integration of a constitutive miRFP670 stably expression construct. NALM6 cells stably express CD19, are ideal for testing CAR T cell or other immunotherapies. NALM6/iRFP cells stably stably express miRFP670, can be used for in vitro assays and in vivo imaging.